• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌醇多磷酸 4-磷酸酶 II 阴性三阴性乳腺癌免疫表型分类中 DNA 损伤传感器和固有免疫信号蛋白的差异丰度。

Differential Abundance of DNA Damage Sensors and Innate Immune Signaling Proteins in Inositol Polyphosphate 4-Phosphatase Type II-Negative Triple-Negative Breast Cancer Classified by Immunotype.

机构信息

Department of Pathology, Hoag Memorial Hospital Presbyterian, Newport Beach, California.

Department of Molecular Biology and Biochemistry, University of California, Irvine, California.

出版信息

Am J Pathol. 2024 Nov;194(11):2212-2232. doi: 10.1016/j.ajpath.2024.07.015. Epub 2024 Aug 13.

DOI:10.1016/j.ajpath.2024.07.015
PMID:39147237
Abstract

The influence of neoplastic cells on the tumor microenvironment is poorly understood. In this study, eight patient samples representing two immunotypes of triple-negative breast cancer (TNBC), defined by quantitative histologic criteria as T-cell desert and T-cell infiltrated (TCI), were compared via label-free quantitative protein mass spectrometry of material extracted directly from targeted regions of formalin-fixed, paraffin-embedded tissue sections. Of 2934 proteins quantitated, 439 were significantly differentially abundant, among which 361 were overabundant in TCI-TNBC. The 361-protein group included proteins involved in major histocompatibility complex-I antigen processing and presentation, viral defense, DNA damage response, and innate immune signaling. Immunohistochemical validation of selected proteins showed good positive correlation between neoplastic cell histoscores and label-free quantitation. Extension of immunohistochemical analysis to a total of 58 inositol polyphosphate 4-phosphatase type II-negative TNBC confirmed elevated levels of the DNA damage sensor interferon-γ-inducible protein 16, inflammasome adaptor apoptosis-associated speck-like protein containing a CARD (ASC), and pore-forming protein gasdermin D in TCI-TNBC neoplastic cells. By contrast, cGMP-AMP synthase inhibitor barrier to autointegration factor (BAF) was elevated in the neoplastic cells of T-cell desert TNBC. These findings demonstrate a previously unknown correlation between the degree of T-cell infiltration in inositol polyphosphate 4-phosphatase type II-negative TNBC and the levels, in cognate neoplastic cells, of proteins that modulate innate immune signaling in response to DNA damage.

摘要

肿瘤细胞对肿瘤微环境的影响尚未被充分认识。在这项研究中,我们比较了 8 个患者样本,这些样本代表了两种三阴性乳腺癌(TNBC)免疫型,根据定量组织学标准定义为 T 细胞荒漠型和 T 细胞浸润型(TCI)。这 8 个样本是通过对福尔马林固定、石蜡包埋组织切片的靶向区域直接提取的物质进行无标记定量蛋白质质谱分析而获得的。在定量的 2934 种蛋白质中,有 439 种蛋白质的丰度存在显著差异,其中 361 种在 TCI-TNBC 中过度表达。361 种蛋白质组包括参与主要组织相容性复合物-I 抗原加工和呈递、病毒防御、DNA 损伤反应和固有免疫信号的蛋白质。对选定蛋白质的免疫组织化学验证显示,肿瘤细胞组织学评分与无标记定量之间存在良好的正相关。对总共 58 例肌醇多磷酸 4-磷酸酶 II 阴性 TNBC 的免疫组织化学分析扩展证实,在 TCI-TNBC 肿瘤细胞中,DNA 损伤传感器干扰素-γ诱导蛋白 16、炎症小体衔接蛋白凋亡相关斑点样蛋白含有 CARD(ASC)和形成孔蛋白的 gasdermin D 的水平升高。相比之下,cGMP-AMP 合酶抑制剂自身整合因子(BAF)在 T 细胞荒漠型 TNBC 的肿瘤细胞中升高。这些发现表明,在肌醇多磷酸 4-磷酸酶 II 阴性 TNBC 中 T 细胞浸润程度与调节固有免疫信号对 DNA 损伤反应的肿瘤细胞中蛋白质水平之间存在以前未知的相关性。

相似文献

1
Differential Abundance of DNA Damage Sensors and Innate Immune Signaling Proteins in Inositol Polyphosphate 4-Phosphatase Type II-Negative Triple-Negative Breast Cancer Classified by Immunotype.肌醇多磷酸 4-磷酸酶 II 阴性三阴性乳腺癌免疫表型分类中 DNA 损伤传感器和固有免疫信号蛋白的差异丰度。
Am J Pathol. 2024 Nov;194(11):2212-2232. doi: 10.1016/j.ajpath.2024.07.015. Epub 2024 Aug 13.
2
Multi-Omics Profiling Reveals Distinct Microenvironment Characterization and Suggests Immune Escape Mechanisms of Triple-Negative Breast Cancer.多组学分析揭示三阴性乳腺癌独特的微环境特征,并提示免疫逃逸机制。
Clin Cancer Res. 2019 Aug 15;25(16):5002-5014. doi: 10.1158/1078-0432.CCR-18-3524. Epub 2019 Mar 5.
3
MYC suppresses STING-dependent innate immunity by transcriptionally upregulating DNMT1 in triple-negative breast cancer.MYC 通过转录上调三阴性乳腺癌中的 DNMT1 来抑制 STING 依赖性先天免疫。
J Immunother Cancer. 2021 Jul;9(7). doi: 10.1136/jitc-2021-002528.
4
INPP4B and PTEN Loss Leads to PI-3,4-P2 Accumulation and Inhibition of PI3K in TNBC.INPP4B和PTEN缺失导致三阴性乳腺癌中PI-3,4-P2积累及PI3K抑制。
Mol Cancer Res. 2017 Jun;15(6):765-775. doi: 10.1158/1541-7786.MCR-16-0183. Epub 2017 Feb 14.
5
Landscape of toll-like receptors expression in tumor microenvironment of triple negative breast cancer (TNBC): Distinct roles of TLR4 and TLR8.肿瘤微环境中三阴性乳腺癌(TNBC)中 Toll 样受体表达的全景:TLR4 和 TLR8 的不同作用。
Gene. 2021 Aug 5;792:145728. doi: 10.1016/j.gene.2021.145728. Epub 2021 May 20.
6
An immune stratification reveals a subset of PD-1/LAG-3 double-positive triple-negative breast cancers.一种免疫分层揭示了PD-1/LAG-3双阳性三阴性乳腺癌的一个亚群。
Breast Cancer Res. 2016 Dec 3;18(1):121. doi: 10.1186/s13058-016-0783-4.
7
MUC1-C integrates activation of the IFN-γ pathway with suppression of the tumor immune microenvironment in triple-negative breast cancer.MUC1-C 可将 IFN-γ 通路的激活与三阴性乳腺癌肿瘤免疫微环境的抑制相结合。
J Immunother Cancer. 2021 Jan;9(1). doi: 10.1136/jitc-2020-002115.
8
Phosphorylation of RAB7 by TBK1/IKKε Regulates Innate Immune Signaling in Triple-Negative Breast Cancer.TBK1/IKKε 对 RAB7 的磷酸化调节三阴性乳腺癌中的固有免疫信号。
Cancer Res. 2020 Jan 1;80(1):44-56. doi: 10.1158/0008-5472.CAN-19-1310. Epub 2019 Oct 29.
9
MxA expression is associated with tumor-infiltrating lymphocytes and is a prognostic factor in triple-negative breast cancer.MxA表达与肿瘤浸润淋巴细胞相关,是三阴性乳腺癌的一个预后因素。
Breast Cancer Res Treat. 2016 Apr;156(3):597-606. doi: 10.1007/s10549-016-3786-z. Epub 2016 Apr 13.
10
Comprehensive characterization of immune landscape of Indian and Western triple negative breast cancers.印度和西方三阴性乳腺癌免疫图谱的综合表征。
Transl Oncol. 2022 Nov;25:101511. doi: 10.1016/j.tranon.2022.101511. Epub 2022 Aug 11.

引用本文的文献

1
Protein-Level Analysis of Differential Response to Chemotherapy in Triple-Negative Breast Cancer Identifies CYP1B1 as a Biomarker for Chemotherapy Resistance.三阴性乳腺癌中化疗差异反应的蛋白质水平分析确定CYP1B1为化疗耐药的生物标志物。
Cancer Res Commun. 2025 Jul 1;5(7):1060-1069. doi: 10.1158/2767-9764.CRC-25-0034.